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Abstract
Background: The PKD family of serine/threonine kinases comprises a single member in Drosophila
(dPKD), two isoforms in C. elegans (DKF-1 and 2) and three members, PKD1, PKD2 and PKD3 in
mammals. PKD1 and PKD2 have been the focus of most studies up to date, which implicate these
enzymes in very diverse cellular functions, including Golgi organization and plasma membrane
directed transport, immune responses, apoptosis and cell proliferation. Concerning PKD3, a role
in the formation of vesicular transport carriers at the trans-Golgi network (TGN) and in basal
glucose transport has been inferred from in vitro studies. So far, however, the physiological
functions of the kinase during development remain unknown.
Results: We have examined the expression pattern of PKD3 during the development of mouse
embryos by immunohistochemistry. Using a PKD3 specific antibody we demonstrate that the
kinase is differentially expressed during organogenesis. In the developing heart a strong PKD3
expression is constantly detected from E10 to E16.5. From E12.5 on PKD3 is increasingly
expressed in neuronal as well as in the supporting connective tissue and in skeletal muscles.
Conclusion: The data presented support an important role for PKD3 during development of
these tissues.
Background
The protein kinase D (PKD) family of serine/threonine
kinases comprises a single member in Drosophila [1,2],
two isoforms in C. elegans [3,4] and three members, PKD1
(PKCμ), PKD2 and PKD3 (PKCν) in mammals. The three
mammalian isoforms share similar structural modules.
They consist of an N-terminal regulatory domain and a C-
terminal kinase domain. While PKD1 and PKD2 posses
an alanine/proline-rich region at their N-terminus, in
PKD3 this hydrophobic domain is absent. All isoforms
contain two cysteine-rich domains (CRD) separated by a
long linker region, an acidic region consisting of nega-
tively charged amino acids and a pleckstrin homology
domain (PH). These characteristic motifs are also impor-
tant for the regulation of enzyme activity and localization
within cells. The PKD enzymes have recently been impli-
cated in very diverse cellular functions, including Golgi
organization and plasma membrane directed transport,
metastasis, immune responses, apoptosis and cell prolif-
eration (for an overview see [5]). PKD3 was originally
identified in 1999 [6]. Northern blot analysis revealed a
ubiquitous expression of the protein in a wide variety of
human tissues suggesting a basic housekeeping function
[6]. In vitro studies propose a potential role of the kinase
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in signaling events of GPCR agonists which induced a
rapid activation of PKD3 by a protein kinase C (PKC)-
dependent pathway [7]. PKD3 can also be activated by
bombesin in a Rac and Gα dependent mechanism [8,9].
Moreover, PKD3 was implicated to play a role in B cell
antigen receptor signaling by phosphorylating class II
HDAC5 and 7 thereby promoting nuclear export of these
proteins [10,11]. Activation of PKD3 in these cells
involves the phosphorylation of the activation loop ser-
ines which is mediated by a DAG-PLC-PKC-dependent
pathway. Putative upstream kinases for PKD3 are PKCε,
PKCη or PKCθ [10]. According to the localization of the
kinase at the trans-Golgi network (TGN) [12], a function
in the formation of exocytotic transport carriers has been
described [13]. Recently, it could be demonstrated that
PKD3 and PKD2 dimerize at the TGN and regulate mem-
brane fission [14]. However, there is also substantial evi-
dence that PKD3 has a distinct and non-redundant
function within the PKD family. Compared to PKD1 and
2, PKD3-specific direct substrates at the TGN have not
been identified yet [12,15]. A PDZ domain identified in
PKD1 and 2 is lacking in PKD3 [16]. Moreover, PKD1 and
PKD2, but not PKD3, are targets for PKCδ in response to
oxidative stress, because PKD3 lacks the relevant tyrosine
residue that generates a PKCδ interaction motif [17].
PKD3 also localizes to vesicular structures that are part of
the endocytic compartment. This localization may be
mediated by the interaction of PKD3 with the vesicle-
associated membrane protein VAMP2 [18]. In L6 skeletal
muscle cells, a specific role for PKD3 in basal glucose
uptake could be demonstrated [19].
The functional activities of PKD3 described so far are
derived from in vitro studies performed with established
cell lines. Transgenic mouse models, which allow interfer-
ence with endogenous PKD3, are not available. Conse-
quently, the in vivo functions of PKD3 remain unknown
so far. In a recent report, Oster and colleagues described
the expression of PKD isoforms during mouse embryo-
genesis using in situ hybridization techniques [20]. In
early stages of development, PKD3 mRNA was clearly
detected in the heart, nasal processes and limb buds. Dur-
ing later stages of development, PKD3 transcript was more
or less ubiquitously present. In an independent study, we
have investigated the expression of PKD3 protein by
immunohistochemistry on sagittal sections of mouse
embryos using a PKD3 specific antibody. We here
describe PKD3 protein expression in developmental stage
E10 through E16.5 of the mouse.
Results and Discussion
Specificity of the PKD3 antibody
The affinity purified polyclonal PKD3 specific antibody
used in this study was generated by immunization of rab-
bits with a peptide corresponding to the C-terminal
epitope of human PKD3 (amino acids 875 to 890). This
epitope is conserved in the mouse orthologous gene, but
not present in PKD1 or PKD2 isoforms (Fig. 1A). To dem-
onstrate that the antibody is specific for PKD3 and not
cross-reactive with PKD1 and PKD2, we performed West-
ern blot analysis. Total cell lysates of HEK293T cells tran-
siently transfected with plasmids encoding GFP-tagged
human PKD1, GFP-tagged human PKD2, and human
Flag-tagged PKD3 were analyzed (Fig. 1B). The PKD3-spe-
cific antibody detected Flag-PKD3, migrating at about 120
kDa, and endogenous PKD3, migrating at about 105 kDa,
but not PKD1 or PKD2, thus demonstrating the specificity
of the reagent. Since no PKD3 mutants are available, the
Specificity of the PKD3 antibody Figure 1
Specificity of the PKD3 antibody. A: Sequence alignment 
of mouse PKD3 with human PKD3, mouse PKD1 and PKD2. 
The sequence of PKD3 used for peptide synthesis and immu-
nisation of mice is marked in red. B: HEK293T cells were 
transfected with the indicated plasmids, whole cell lysates 
were prepared and Western blot analysis was performed 
with the indicated antibodies. C: Immunohistochemistry on 
sagittal sections (6 μm) of E14.5 mouse embryos. Sections 
incubated with mouse Flag- and rabbit GFP-specific antibod-
ies (both 0.5 μg/ml), respectively or without primary anti-
body (-) were negative and used as control. Section 
incubated with rabbit anti-PKD3 antibody (1:2000) displayed 
specific staining.BMC Developmental Biology 2008, 8:47 http://www.biomedcentral.com/1471-213X/8/47
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antibody could not be tested in a PKD3 deficient back-
ground. We have therefore applied several approaches to
confirm specificity of the PKD3 antibody used here; con-
trol staining procedures performed without the primary
antibody or with rabbit preimmune-serum were all nega-
tive. Various antibody dilutions (1:500 – 1:2000) had no
effect on the staining pattern (data not shown). In addi-
tion, we performed staining with either Flag-specific
mouse monoclonal or GFP-specific rabbit polyclonal
antibodies that was negative, too (Fig. 1C).
PKD3 expression in early and later stages of development
Performing immunohistochemistry on paraffin sections
of mouse embryos at developmental stage E10 – E16.5 we
obtained histological details of PKD3 expression.
In E10.0 the most prominent expression was evident in
the developing heart (Fig 2C, D and 2E). Cells forming the
ventricular and atrial chambers showed a strong staining
(Fig. 2E and 2I). This strong expression in the heart was
visible from early to late stages of embryonic development
(Fig. 2, 3, 4, 5, 6, 7). Recent work suggests an important
role for the PKD kinase family in cardiac myocytes. The
expression of PKD1 and PKD2 or PKD3 was demon-
strated in neonatal and adult rat ventricular myocytes as
well as adult mouse, rat, rabbit, and human myocardium
(for an overview see [21]). Of note, the PKD expression
seems to be subject to developmental regulation and
declines significantly in adulthood [22]. Furthermore,
studies with transgenic mice revealed a role for PKD1 in
pathological cardiac remodeling. Cardiac-specific expres-
sion of a constitutive active PKD1 in vivo caused hypertro-
phy, chamber dilation, and impaired systolic function
[23]. Conversely, mice with a cardiac specific PKD1
knock-out demonstrated an impaired response to stress
signals that normally lead to cardiac hypertrophy, fibrosis
PKD3 expression at embryonic stage E10 Figure 2
PKD3 expression at embryonic stage E10. Immunohistochemistry was performed on sagittal sections (6 μm) of E10 
mouse embryos. (A) – (B) Control sections incubated without primary antibody. (C) – (I) Sections incubated with anti-PKD3 
antibody (1:2000). ac: atrial chamber, ba: branchial arch, da: dorsal aorta, dm: dermomyotome, flb: forelimb bud, hlb: hindlimb 
bud, nc: notochord, np: nasal process, nt: neural tube, op: olfactory pit, som: somites, vh: ventricular chamber of heart. Scale 
bars: 100 μm.BMC Developmental Biology 2008, 8:47 http://www.biomedcentral.com/1471-213X/8/47
Page 4 of 10
(page number not for citation purposes)
and fetal gene activation [24]. There is substantial evi-
dence that this phenotype is associated with the PKD-
mediated phosphorylation of class II HDAC5. However,
each PKD isoform is capable of phosphorylating class II
HDACs on the serines that mediate nuclear export via
interaction with 14-3-3 proteins [11,25], suggesting that
PKD family members could act redundant. Although the
diminished hypertrophic response of PKD1 cardiac
knock-out mice indicates that PKD2 and 3 cannot fully
compensate for the loss of PKD1 it is likely that the resid-
ual hypertrophy and fetal gene activation in these animals
reflects redundant functions of cardiac PKD2 and 3.
In addition, PKD3 was expressed in the nasal processes
(Fig. 2D, E and 2H) and forelimb buds (Fig. 2I). These
observations are in line with previously published data on
mRNA distribution at this stage [20]. On top of this, an
obvious PKD3 expression was also visible in the embry-
onic mesoderm. Especially somite derived structures
forming the dermomyotome (Fig. 2F, G and 2I) and the
notochord (Fig. 2G, H) were PKD3 positive. Of note,
PKD3 was not expressed in erythrocytes present in the
atrium and the dorsal aorta (Fig. 2F and 2I). In contrast to
in situ hybridization studies [20] PKD3 protein could not
be detected in the forebrain or midbrain region at this
stage. This might be due to low levels of PKD3 mRNA at
this stage [20], which might result in low protein levels
that are difficult to detect and/or additional regulation of
PKD3 expression at the posttranscriptional level in this
tissue.
PKD3 expression at embryonic stage E11.5 Figure 3
PKD3 expression at embryonic stage E11.5. Immunohistochemistry was performed on sagittal sections (6 μm) of E11.5 
mouse embryos. (A) – (B) Control sections incubated without primary antibody. (C) – (J) Sections incubated with anti-PKD3 
antibody (1:2000). ac: atrial chamber, bs: cartilage primordium of base of the skull, C1: condensation of sclerotomic material 
forming centrum of atlas, cm: cephalic mesenchyme, da: dorsal aorta, ec: endocardial cushion tissue lining the atrio-ventricular 
canal, lb: lung bud, mb: main bronchus, nc: notochord, np: nasal process, op: olfactory pit, rh: roof of hindbrain, vh: ventricular 
chamber of heart. Scale bars: 100 μm.BMC Developmental Biology 2008, 8:47 http://www.biomedcentral.com/1471-213X/8/47
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In embryonic stage E11.5 PKD3 expression was detectable
in additional tissues (Fig. 3C and 3D). Parts of the head
region near the developing base of the scull and nasal
process (Fig. 3E) were positive for PKD3 protein. PKD3
expression was visible in and along the notochord, where
sclerotomic material is condensed to form the centrum of
the axis (Fig. 3H and 3J). A strong PKD3 expression was
detected in the bronchus of the lung bud (Fig. 3J)
restricted to the cytoplasm of the epithelium. PKD3
expression in the cardiac muscle cells was still obvious
(Fig. 3F, G). Moreover, PKD3 was expressed in the wall of
the dorsal aorta at this stage (Fig. 3H and 3I).
In embryonic stage E12.5 more cytological details of
PKD3 expression were visible (Fig. 4C, D). PKD3 was
detected in the cartilage primordium of nasal bones (Fig.
4E), the temporal bones (Fig. 4J) and the vertebra (Fig.
4F). PKD3 expression was still detectable in the noto-
chord (Fig. 4F and 4F") and in cardiomyocytes forming
the ventricular and atrial chambers but was absent from
the atrio-ventricular bulbar cushion tissue (Fig. 4G). Fur-
ther, the membrane of the oesophagus showed a strong
PKD3 expression (Fig. 4F and 4F'). Within the lung strong
PKD3 expression was found in epithelial cells of segmen-
tal bronchii (Fig. 4H). PKD3 expression is also observed
in the urogenital ridge surrounding the lumen of the uro-
genital sinus (Fig. 4I). Moreover, PKD3 expression now
became detectable in the developing brain, with a promi-
nent staining of the outer layer of the choroid plexus
within the fourth ventricle (Fig. 4K). In the stomach, the
mucous membrane was PKD3 positive (Fig. 4L).
In embryonic stage E13.5 PKD3 was found to be more or
less ubiquitously expressed (Fig. 5C and 5D). In addition
to PKD3 positive structures like cardiomyocytes (Fig. 5E),
the protein could also be detected in further muscle struc-
tures: Skeletal muscle cells of the neck region (Fig. 5F) as
well as muscles of the tongue (Fig. 5G and 5G') showed
strong PKD3 expression. In the lung, the epithelial layer of
the segmental but not the main bronchi was positive (Fig.
5H, H'). A prominent PKD3 expression could be detected
in the middle layer (submucosa) of the stomach, but not
the inner layer (mucosa) (Fig. 5I and 5I'). Prominent sites
of PKD3 expression were also detected in the marginal
layer of the spinal cord (Fig. 5J) and the choroid plexus
within the fourth ventricle (Fig 5K and 5K'). Expression of
PKD3 expression at embryonic stage E12.5 Figure 4
PKD3 expression at embryonic stage E12.5. Immunohistochemistry was performed on sagittal sections (6 μm) of E12.5 
mouse embryos. (A) – (B) Control sections incubated without primary antibody. (C) – (L) Sections incubated with anti-PKD3 
antibody (1:2000). bc: atrio-ventricular bulbar cushion tissue, cp: origin of choroid plexus, cv: cartilage primordium of vertebra, 
da: descending (thoracic) aorta, dt: dorsum of tongue, fv: fourth ventricle, ll: left lung, ls: lumen of stomach, lv: lateral ventricle, 
ml: marginal layer of spinal cord, mm: mucous membrane, nc: nasal cavity, not: notochord, np: nasopharynx, oe: olfactory epi-
thelium, op: oesophagus, or: optic recess of diencephalon, pc: pericardial cavity, pl: pleural cavity, rg: root ganglia, sb: segmental 
bronchus, sc: spinalcord, tb: cartilage primordium of temporal bone, ul: upper lip, us: urogenital sinus, vo: vomeronasal organ. 
Scale bars: 100 μm.BMC Developmental Biology 2008, 8:47 http://www.biomedcentral.com/1471-213X/8/47
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PKD3 was also detected in the developing bones. Espe-
cially the cartilage primordium of turbinate bones (Fig.
5L) and osteoblasts in the vertebrae which secrete bone
material into previously existing cartilage matrix were
intensively stained (Fig. 5M and 5M'). The membranous
layer surrounding cartilage during ossification, the peri-
chondrium, was also positive for PKD3 expression (Fig.
5M'). Of note, the ventricular zone of the neocortex as
well as the liver was negative (Fig 5C and 5D).
PKD3 expression in osteoblasts was even more prominent
in stage E14.5 in developing bones of the spinal column
(Fig. 6G). The nucleus pulposus in the middle of the spi-
nal disc was also intensively stained (Fig. 6H, H'). Skeletal
muscle cells of the diaphragm (Fig. 6I, I') also showed a
strong PKD3 expression. Oster and colleagues failed to
detect elevated levels of PKD3 mRNA in skeletal muscle
by in situ hybridization [20]. The reason for this seeming
discrepancy is unclear and might be of technical nature or
reflect the fact that the level of mRNA does not necessarily
correlate with the protein level.
In this stage we found a strong expression in the kidney
capsule (Fig. 6J, J'), in terminal bronchioles of the lung
(Fig. 6K), in the nuclei of distinct cells of the liver (Fig. 6L)
as well as in the middle layer of the duodenum (Fig. 6M).
In the brain, PKD3 expression was ubiquitously detected
with exception of the neocortex, which was negative (Fig.
6D, E, F). Interestingly, in the medulla oblongata distinct
nerve tracts were intensively stained for PKD3 (Fig. 6N);
moreover, the choroid plexus within the fourth and lateral
ventricle was also positive (Fig. 6E, O). In accordance with
published data on PKD3 mRNA expression [20] the inner
layer of the retina shows a weak PKD3 specific staining,
whereas the extrinsic ocular muscle displays a strong
expression of PKD3 (Fig. 6P). Interestingly, cells within
the olfactory epithelium displayed a strong PKD3 signal
within the nuclei (Fig. 6Q). The root sheath of the
Whisker follicles showed a steady PKD3 expression in
E14.5 and E16.5 (Fig. 6R, R', and 7H). Furthermore, the
suprabasal layer of the epidermis as well as underlying
connective tissue (Fig. 6S) are positive for PKD3. The epi-
dermal staining was impressively evident in the mouth
PKD3 expression at embryonic stage E13.5 Figure 5
PKD3 expression at embryonic stage E13.5. Immunohistochemistry was performed on sagittal sections (6 μm) of E13.5 
mouse embryos. (A) – (B) Control sections incubated without primary antibody. (C) – (N') Sections incubated with anti-PKD3 
antibody (1:2000). bb: cartilage primordium of basioccipital bone (clivus), cp:choroid plexus, cr: cartilage primordium of ribs, dt: 
dorsum of tongue, fv: fourth ventricle, hb: cartilage primordium of body of hyoid bone, li: liver, ll: lower lip, ls: lumen of stom-
ach, lu: lung, mb: main bronchus, mc: mucosal lining, ml: marginal layer of spinal cord, mt: muscle mass of the tongue, nc: neo-
cortex, oe: olfactory epithelium, or: optic recess of diencephalon, os: osteoblasts, pc: pericardial cavity, pe: perichondrium, pl: 
pleural cavity, pm: pons-midbrain junction, rg: root ganglion, sb: segmental bronchus, sc: spinal cord, sm: submucosa, st: stom-
ach, tb: cartilage primordium of turbinate bones, tp: tooth primordium, ul: upper lip, vc: vena cava. Scale bars: 100 μm.BMC Developmental Biology 2008, 8:47 http://www.biomedcentral.com/1471-213X/8/47
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region where PKD3 negative endoderm and PKD3 posi-
tive ectoderm derived epidermal layers came into direct
contact (Fig. 6T). PKD3 is also expressed in the first pri-
mordium of the upper molar tooth (Fig. 6U), which is
formed by an incorporation of dental epithelium.
PKD3 was found to be more ore less ubiquitously
expressed in embryonic stage E16.5 (Fig. 7C and 7D). Par-
ticularly strong PKD3 expression was detected in nerve
tracts in the pons (Fig. 7E) and the choroid plexus of the
lateral and fourth ventricle (Fig. 7F, G). The middle layer
(submucosa) but not the mucosa or the muscle layer (Fig.
7I) demonstrated PKD3 expression. In contrast to E13.5,
the submucosa of the stomach showed only a weak PKD3
expression, however, smooth muscle cells in the muscula-
ris layer of the stomach were still PKD3 negative (Fig. 7J,
J'). Within the liver PKD3 expression seemed to be further
increased (Fig. 7C, D), which is in accordance with high
mRNA levels detected by in situ hybridization in E18.5
[20]. The strong PKD3 expression in the kidney capsule
(Fig. 7K) and in the terminal bronchi of the lung (Fig. 7L)
detected in E14.5 was even more evident. In the region of
the lower lip, the intensive staining of the suprabasal layer
of the epidermis was obvious (Fig. 7M). All skeletal mus-
cle cells within the embryo showed a strong PKD3 expres-
sion (Fig 7N–R) e.g. intercostal muscle cells (Fig. 7N) and
the transverse muscle fibers of the tongue (Fig. 7O). Inter-
estingly, PKD3 distribution in skeletal muscle cells of the
diaphragm (Fig. 7P) and the neck region (Fig. 7Q) is
polarized, especially visible in cross-sections (Fig. 7Q). Of
note, PKD3 was not detected in smooth muscle cells and
in the thymus at this stage. Interestingly, Oster and col-
PKD3 expression at embryonic stage E14.5 Figure 6
PKD3 expression at embryonic stage E14.5. Immunohistochemistry was performed on sagittal sections (6 μm) of E14.5 
mouse embryos. (A) – (C) Control sections incubated without primary antibody. (D) – (U) Sections incubated with anti-PKD3 
antibody (1:2000). bl: basal layer of epidermis, ce: cerebellum, cp: choroid plexus, du: duodenum, il: inner layer of retina, kc: 
kidney capsule, ki: kidney, ld: lumen of duodenum, le: lens, li: liver, lv: lateral ventricle, mb: main bronchus, md: muscle of dia-
phragm, mf: muscle fibers, ml: marginal layer of spinal cord, mo: medulla oblongata, mr: medulla renalis, mt: primordium of 
upper molar tooth, mu: muscularis layer of duodenum, nb: cartilage primordium of the nasal bone, nc: nasal cavity, nl: neural 
layer of retina, np: nucleus pulposus in the central region of future invertebral disc, oe: olfactory epithelium, op: oesophagus, 
or: oropharynx, rg: root ganglia, rp: renal pelvis, sc: spinal cord, scl: sclera, sl: suprabasal layer of epidermis, sm: submucosal 
layer of duodenum, sp: cartilage primordium of spinal column, st: stomach, tb: terminal bronchus, th: thymus, tt: tip of the 
tongue, ul: upper lip, vi: primordia of follicles of vibrissae. Scale bars: 100 μm.BMC Developmental Biology 2008, 8:47 http://www.biomedcentral.com/1471-213X/8/47
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leagues could detect PKD3 mRNA in the thymus at E18.5
[20]. In line with this, Western blot analysis revealed a
strong PKD3 expression in the thymus of adult animals
(unpublished observation K. Ellwanger), suggesting an
increase in the expression level of PKD3 protein in neona-
tal mice.
Conclusion
The expression pattern of PKD3 reveals a tissue selective
expression at stage E10, which became more abundant
and distributed later on during embryonic development.
Our data are in accordance with previously published
results on PKD3 mRNA levels using in situ hybridization
analysis [20]. On top of that, we provide a comprehensive
study on the expression pattern of PKD3 during organo-
genesis discovering additional histological details. The
strong expression of PKD3 in specific tissues, e.g. cardiac
and skeletal muscle, points to an important role for this
kinase in the development of these tissues. PKD3 has been
implicated in the regulation of secretory transport proc-
esses at the Golgi compartment [13,14] as well as regula-
tion of basal glucose uptake in skeletal muscle cells [19],
both of which are important processes during organogen-
esis. Moreover, PKD3 has been shown to regulate the
nuclear localization and thus activity of its physiological
substrates class II HDAC5 and 7 [11]. Interestingly, class
PKD3 expression at embryonic stage E16.5 Figure 7
PKD3 expression at embryonic stage E16.5. Immunohistochemistry was performed on sagittal sections (6 μm) of E16.5 
mouse embryos. (A) – (B) Control sections incubated without primary antibody. (C) – (Q) Sections incubated with anti-PKD3 
antibody (1:2000). bl: basal layer of epidermis, cc: costal cartilage, cp: choroid plexus, dt: dorsum of tongue, du: duodenum, fu: 
fundus region of stomach, fv: fourth ventricle, im: intercostal muscle, kc: kidney capsule, ki: kidney, ld: lumen of duodenum, li: 
liver, ll: lower lip, lu: lung, lv: lateral ventricle, mb: main bronchus, md: muscle fibers of diaphragm, mf: muscle fibers, mr: 
medulla renalis, mt: muscle mass of the tongue, mu: muscularis layer, nr: neck region, po: pons, sl: suprabasal layer of epidermis, 
sm: submucosal layer, tb: terminal bronchus, vi: primordia of follicles of vibrissae. Scale bars: 100 μm (E) – (Q), 10 μm (R).BMC Developmental Biology 2008, 8:47 http://www.biomedcentral.com/1471-213X/8/47
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II HDAC proteins play an important role in heart develop-
ment and function [26,27]. It will now be exciting to
investigate the potential function of PKD3 in these tissues
using transgenic mouse models, interfering with endog-
enous PKD3 function by overexpression of a dominant-
negative protein or deletion of the PKD3 gene (knock-
out).
Methods
Antibodies
The primary antibody used in this study was an affinity-
purified PKD3 specific polyclonal antibody raised in rab-
bits against a C-terminal epitope of human PKD3 (amino
acids 875-890). The mouse monoclonal GFP- and Flag-
specific antibodies were obtained from Roche Biosciences
and Sigma-Aldrich, respectively. The rabbit polyclonal
GFP-specific antibody was from Santa Cruz Biotechnol-
ogy. The secondary IRdye-conjugated antibodies were
from Li-COR Biosciences. Transfection of HEK293T cells
was performed as described in [12].
Animals
C57BL/6 mice were time mated and pregnant females
were sacrificed to collect the embryos at different stages
(E10 – E16.5). The finding of a vaginal plug at noon was
considered as E0. The fetuses were isolated from the
uterus and dissected free of embryonic membranes in ice-
cold PBS. All animal experiments carried out in this study
were approved by the ethical committee at the University
of Stuttgart.
Western Blot
Cells were harvested and lysed in lysis buffer (20 mM Tris
(pH7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and
1% Triton X-100, plus protease and phosphatase inhibi-
tors). Equal amounts of protein were subjected to a 4–
12% NuPAGE Bis-Tris-Gel (Invitrogen, Germany), blotted
onto a nitrocellulose membrane and blocked with 0.5%
blocking buffer (Roche Biosciences, Germany). Incuba-
tion with primary antibodies was performed in blocking
buffer at 4°C overnight. After washing with PBS, samples
were incubated with secondary IRdye680-conjugated
anti-mouse or IRdye800-conjugated anti-rabbit IgG anti-
bodies in blocking buffer for 1 h at room temperature. The
detection was performed on an Odyssey Infrared Imaging
System (Li-COR Biosciences, Germany).
Immunohistochemistry
After fixation with paraformaldehyde embryos were dehy-
drated through a graded ethanol series and into a 50:50
mixture of ethanol:Histoclear (Carl Roth GmbH, Karl-
sruhe, Germany). Tissue was then incubated in Histoclear
for 1–3 hours and transferred into a 50:50 mixture of
Histoclear:Paraplast (Carl Roth GmbH, Karlsruhe, Ger-
many) at 42°C, where it was incubated over night.
Embryos were transferred into pure Paraplast preheated to
60°C and incubated for 1–3 days. Serial sagittal sections
were cut at a thickness of 10 μm on a microtome and
floated on a 40°C water bath. Sections were dewaxed in 3
changes of Roticlear for 10 minutes each and incubated in
isopropanol and ethanol 15 minutes each. Slides were
rehydrated through a reverse series of ethanol dilutions in
PBS and finally washed in PBS. Endogenous peroxidase
activity was quenched by incubation in PBS containing
0.3% H2O2 for 30 minutes. Slides were rinsed with PBS for
10 minutes and then incubated with 5% normal goat
serum in a humidified chamber to block unspecific bind-
ing sites. Primary antiserum diluted in 1.5% normal goat
serum was applied. Slides were incubated in the humidi-
fied chamber at 4°C over night.
Immunohistochemical staining was performed using the
Vectastain Elite ABC Kit (rabbit IgG) (Vector Laboratories,
Burlingame, CA, USA). To remove non-specifically bound
antibody, slides were washed three times in PBS for 10
minutes each time. Subsequently, sections were incubated
with biotinylated goat anti-rabbit IgG diluted 1:200 in
1.5% normal goat serum for 1 hour at room temperature.
In case of the mouse monoclonal Flag-specific antibody, a
biotin-SP-conjugated goat anti-mouse IgG (Jackson
Immunoresearch, West Grove, PA, USA) diluted 1:500 in
1.5% normal goat serum was used as secondary antibody.
After the slides had been rinsed in PBS as before, immu-
noperoxidase staining was performed. Sections were incu-
bated with the Vectastain Elite ABC reagent (prepared 30–
60 minutes before use) for 30 minutes and washed three
times with PBS for 5 minutes each time. For peroxidase
visualization the DAB Substrate Kit for peroxidase (Vector
Laboratories, Burlingame, CA, USA) was used. Color
development was stopped by rinsing the sections in water
for 5 minutes. Sections were counterstained with hema-
toxylin for 1 minute and coverslipped with Mowiol (Poly-
sciences, Warrington, PA, USA) or Eukitt (EMS, Fort
Washington, PA, USA).
Microscopy and image processing
Stained sections were analyzed using a widefield micro-
scope (Zeiss Axiovert 200 M) equipped with the AxioCam
HRC (Zeiss, Germany) and an Achroplan 10×/0,25 Ph1 or
a LD Achroplan 40×/0,60 Korr Ph2 (DICIII) objective.
Images were further processed with Axiovision software
version 4.5 (Zeiss, Germany).
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